
About
Evercyte GmbH develops human cell-based models and extracellular vesicle products for preclinical testing, drug screening, and biotechnology applications. It also provides cell line development, assay-ready cells, and EV-related services for researchers and companies working with human-relevant in vitro systems. The company is based in Vienna, Austria.
Services
Cell line development
Develops primary cells into immortalized, reprogrammed, or assay-ready cell lines and can source tissue, isolate primary cells, and characterize cell phenotype and bioassays.
Drug screening
Tests compounds for cytotoxic, senolytic, anti-fibrotic, neo-angiogenic, wound healing, and cytokine-targeting effects using human-relevant cell cultures.
Extracellular vesicles
Provides EV-related services including EV enrichment, purification, characterization, potency testing, and production from telomerized or customer-derived cells.
Gene editing studies
Offers gene editing-related studies as part of its service portfolio.
- What to send
- Primary cells to be immortalized · Shipping/billing address · Information on cell type / source · Donor specifications · Information on in vitro culture · Primary cells derived from customer, if applicable · Information on compound(s) to be tested · Customer name, organization, affiliation, email, phone number, shipping/billing address, and comments/questions for pers · Cell type/source, donor specifications, cell type characteristics, and in vitro culture information for immortalization · Primary cells derived from customer, with ethical approval status and related culture, biosafety, sterility, STR, and vi
Capabilities
- Assays and studies
- Cytotoxicity · Proliferation · Cytokine targeting · Senolytic activity · Senomorphic activity · Anti-fibrotic activity · Neo-angiogenic potential · Wound healing activity · 2D proliferation assay · 3D sprouting assay · Fibroblast migration promoting activity · Scratch assay
8 more
EV potency testing · EV marker profiling · Cryo-EM · Drug screening · Toxicity studies · Potency evaluation · Functional testing · Cell characterization - Scale and capacity
- Cell factories for EV production · Cell lines for EV production
- Therapeutic areas
- Biomedicine · Biotechnology · Toxicology · Preclinical testing
Instruments and platforms
- Cryo-EM
- Organ-on-a-chip systems
- Microfluidic kits
- Nortis Inc. MPS
- Nikon application note
Modalities and species
- Modalities
- Gene editing
- Species and models
- Human · Adipose tissue · Bone marrow · Colon · Cornea · Dental pulp · Endometrium · Kidney · Lung · Mammary gland · Muscle · Placenta
4 more
Skin · Thymus · Umbilical cord · Vascular system
Industries served
- Biomedicine
- Biotechnology
- Toxicology
- Preclinical testing
Company
- Quality
- Extended routine quality control systems · MISEV2023 criteria (extracellular vesicle characterization) · ethical approval and informed consent (tissue sourcing) · highest quality standards (cell line generation) · routine quality control systems (cell line development) · mycoplasma tests (included in all studies for personalized cell line development) · authentication (cell line development) · sterility tests (requested information for personalized cell line development)
Locations
- Address
- Leberstrasse 20 1110 Vienna Austria VAT: ATU66244913 office
- Sites
- Vienna, Austria
Contacts
- Phone
- +43 (0) 1 391 44 22
Similar labs
Work here? Claim this listing